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Abstract
Arrhythmogenic cardiomyopathy (ACM) encompasses a group of inherited cardiomyopathies 
including arrhythmogenic right ventricular cardiomyopathy (ARVC) whose molecular disease 
mechanism is associated with dysregulation of the canonical WNT signalling pathway. Recent 
evidence indicates that ARVC and ACM caused by pathogenic variants in the FLNC gene 
encoding filamin C, a major cardiac structural protein, may have different molecular mechanisms 
of pathogenesis. We sought to identify dysregulated biological pathways in FLNC-associated 
ACM.
RNA was extracted from seven paraffin-embedded left ventricular tissue samples from deceased 
ACM patients carrying FLNC variants and sequenced.
Transcript levels of 623 genes were upregulated and 486 genes were reduced in ACM in 
comparison to control samples. The cell adhesion pathway and ILK signalling were among the 
prominent dysregulated pathways in ACM. Consistent with these findings, transcript levels of cell 
adhesion genes JAM2, NEO1, VCAM1 and PTPRC were upregulated in ACM samples. Moreover, 
several actin-associated genes, including FLNC, VCL, PARVB and MYL7, were suppressed, 
suggesting dysregulation of the actin cytoskeleton. Analysis of the transcriptome for dysregulated 
biological pathways predicted activation of inflammation and apoptosis and suppression of 
oxidative phosphorylation and MTORC1 signalling in ACM.
Our data suggests dysregulated cell adhesion and ILK signalling as novel putative pathogenic 
mechanisms of ACM caused by FLNC variants which are distinct from the postulated disease 
mechanism of classic ARVC caused by desmosomal gene mutations. This knowledge could help 
in the design of future gene therapy strategies which would target specific components of these 
pathways and potentially lead to novel treatments for ACM.
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1. Introduction
Arrhythmogenic cardiomyopathy (ACM) is an important cause of sudden cardiac death 
(SCD) in those under 35 years of age [1]. ACM is characterised by global or regional 
ventricular dysfunction associated with fibro-fatty replacement of the myocardium, 
conduction defects, and arrhythmias [2].
Arrhythmogenic right ventricular cardiomyopathy (ARVC), a major subtype of ACM, is 
considered a disease of the desmosome, commonly caused by mutations in genes coding for 
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major desmosomal proteins [2,3]. Canonical WNT signalling has been implicated in the 
pathogenesis of classic ARVC caused by mutations in desmosomal genes [4]. However, the 
role of this signalling pathway in other subtypes of ACM is unknown.
Pathogenic variants in the FLNC gene encoding filamin C, also known as actin binding like 
protein γ-filamin, a major structural protein, have been recognised to cause several 
cardiomyopathies associated with SCD including ACM [5–8]. We recently studied the 
clinical and molecular “signature” of FLNC-associated disease in pedigrees with ACM as 
well as in fixed cardiac tissue specimens from deceased ACM cases with FLNC pathogenic 
variants [9]. In that study immunohistochemistry analysis provided early evidence that the 
pathogenic mechanism related to genetic variants in FLNC may be different to typical 
ARVC [9]. However, currently the disease mechanisms related to FLNC are mostly 
unknown as is the molecular pathogenesis of ACM caused by FLNC variants. The purpose 




Fixed cardiac tissue from six deceased ACM cases with FLNC variants was obtained 
through a collaborative research project between Spanish pathology centres and hospitals as 
previously described [9]. All cases were sudden cardiac death victims with a diagnosis of 
ARVC or left dominant arrhythmogenic cardiomyopathy at post mortem. [9]. FLNC variants 
include five pathogenic and one variant of unknown significance according to the American 
College of Medical Genetics (ACMG) variant classification [10]. In addition, one ACM case 
carrying the novel c.7252–1G>A splicing variant in FLNC (also classified as pathogenic) 
was identified from sudden death archive cases in the UK. All cases were negative for 
pathogenic variants in other known ACM genes. A list of FLNC variants present in samples 
used in this study is provided in Appendix Table A.1.
In total, paraffin embedded left ventricular (LV) tissue samples were available from seven 
patients for RNA extraction and sequencing. Paraffin fixed LV samples from four age-
matched individuals, who died from non-cardiac conditions, were used as controls.
All procedures performed in studies involving human participants were in accordance with 
the ethical standards of the relevant NHS Health Research Authority Ethics Committees 
(REC ID: 15/LO/0549) in the UK, CEIC Hospital Virgen de la Arrixaca, – CEIC Hospital 
Universitario y Politécnico La Fe in Spain and with the 1964 Helsinki declaration and its 
later amendments. Human samples and data on sudden death cases were collected with 
informed consent from first-degree family members.
2.2. RNA sequencing
RNA from LV tissue was extracted and sequenced by Qiagen as a commercial service 
project. Detailed methodology is provided in the Appendix (Supplementary methods).
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Advanced bioinformatic data analysis and interpretation was completed in-house using 
WebGestalt, g:Profiler (g:GOSt) and Qiagen Ingenuity Pathway Analysis (IPA) as described 
in detail in the Supplementary material, Appendix.
2.4. Quantitative polymerase chain reaction (qPCR)
Comprehensive validation of changes in the transcript levels of the target genes, detected by 
RNA-seq, was not feasible due to limited amount of tissue samples available. Therefore, 
changes in the transcript levels of selected genes related to the predicted dysregulated 
pathways were investigated by qPCR. In particular, Taqman assays (Thermo Fisher 
Scientific) were used for five genes: FLNC, Hs00155124_m1; VCL, Hs00419715_m1; 
PARVB, Hs00203381_m1; THBS4, Hs00170261_m1; MYL7, Hs01085598_g1 
(Supplementary methods, Appendix Table A.2).
3. Results
3.1. RNA sequencing quality
On average 53.1 million reads were obtained per sample. It is estimated that 40 million reads 
per sample for total RNA-seq is sufficient for detecting differential expression of genes [11]. 
Approximately, 26.4% of the sequence reads were mapped to the reference human genome 
assembly GRCh37 (hg19) and were used in subsequent analysis.
3.2. Differentially expressed genes (DEGs)
Analysis of RNA-seq data led to identification of 623 upregulated genes, 486 downregulated 
genes, 92 upregulated isoforms and 127 downregulated isoforms, all with a q value <0.05, in 
ACM hearts as compared to controls (Fig. 1A). The DEGs were targets of a number of 
transcriptional regulators, including STAT1, IRF family of transcription factors, CEBPB and 
CTNNB1, which were predicted, based on their target transcript levels, to be among the 
most activated transcriptional regulators, whereas TRIM24 and MYCN were predicted to be 
among the most suppressed transcriptional regulators (Fig. 1B and C).
The DEGs identified were filtered as shown in Appendix Fig. A.1A and B to produce a gene 
list for Gene Ontology (GO) terms and pathway analysis by different software programmes. 
In accord with the known interactions of FLNC with the actin cytoskeleton in striated 
muscles and its perceived functions in localization of signalling receptors and the structural 
organization of Z-discs [12], the most enriched Gene Ontology terms found by both 
WebGestalt and g:GOSt included ‘cell adhesion’ (p = 5.70 × 10−23), ‘extracellular matrix 
organization’ (p = 4.91 × 10−22) and ‘circulatory system development’ (p = 1.24 × 10−12) 
(Fig. 2 and Appendix Table A.3). Gene set enrichment analysis (GSEA) also identified 
enrichment of genes involved in cell adhesion among the DEGs (Fig. 1D). Heat map of the 
dysregulated genes involved in the cell adhesion pathway is shown in Fig. 1E. Thus, the 
mutant FLNC proteins appear to have an impact on the molecular composition of the 
extracellular matrix (ECM) and the proteins involved in cell adhesion or the regulation of 
cell adhesion.
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WebGestalt was also used to identify the most enriched KEGG pathways, as shown in 
Appendix Table A.4. The most dysregulated KEGG pathway, which contained FLNC and 23 
other dysregulated genes in the dataset, was the “focal adhesion” pathway (p = 5.67 × 10−5). 
The ‘protein digestion and absorption’ and ‘ECM-receptor interaction’ KEGG pathways 
were also dysregulated (p = 6.78 × 10−6 and p = 9.17 × 10−6 respectively).
In the focal adhesion KEGG Pathway (https://www.genome.jp/kegg-bin/show_pathway?
map04510 [13] - Appendix Fig. A.2), 18 genes were upregulated and six genes were 
downregulated in the cardiac tissue from FLNC variant carriers compared to control cardiac 
tissue. The pathway contains several abbreviations for terms, which group multiple genes 
under the same category, including, ECM and GF (growth factor).
To identify enriched pathways within the dataset, after filtering for significance (q < 0.05), 
genes and isoforms were combined and uploaded to IPA (Qiagen). This identified a number 
of dysregulated pathways, including those involved in inflammation and ILK signalling 
among the major dysregulated pathways (Fig. 3A). The corresponding heat map of DEGs in 
the ILK pathway is presented in Fig. 3B and a Circos map showing the DEGs in the main 
dysregulated pathways, namely those involved in inflammation and ILK signalling, is shown 
in Fig. 3C.
The two most significantly enriched canonical pathways identified by IPA (Appendix Fig. A.
3) are the ‘integrin linked kinase pathway’ (ILK pathway, Fig. 4) which contains FLNC (p = 
2.17 × 10−5) and the ‘hepatic fibrosis pathway’ (p = 7.75 × 10−7). It is worth noting that the 
canonical WNT signalling pathway does not appear to be dysregulated in FLNC cardiac 
samples.
3.3. Confirmation analysis with qPCR
Changes in the transcript levels of selected DEGs were further validated by qPCR on RNA 
extracted from the same paraffin cardiac samples used in the RNA sequencing process. Five 
genes in the ILK pathway, FLNC, VCL, PARVB, THBS4 and MYL7, were confirmed to 
show the same pattern of dysregulation as found by RNA sequencing at a statistically 
significant level (p < 0.0001 and p < 0.05) (Appendix Fig. A.5A). In the cell adhesion 
pathway, two genes, JAM2, NEO1, showed statistically significant increased transcription 
levels compared to controls (Appendix Fig. A.5B). Two additional genes, VCAM1 and 
PTPRC, showed undetectable transcript levels in control tissue samples but had detectable 
transcript levels in FLNC cardiac samples (Appendix Fig. A.5B).
4. Discussion
We defined transcriptomic profiles in 7 LV samples from patients with ACM and 4 controls 
and identified DEGs in ACM samples associated with pathogenic variants in the FLNC 
gene. The notable findings were dysregulated pathways pertaining to cell adhesion, 
extracellular matrix protein, and inflammation. The findings were replicated across multiple 
bioinformatics platforms and were partially validated by qPCR of selected target genes 
pertaining to the dysregulated pathways. Overall, the most significantly enriched pathways 
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were: the focal adhesion pathway, the protein digestion and absorption pathway, and ECM 
receptor interaction pathway.
The above three KEGG pathways are intrinsically linked and there is a great degree of 
overlap with a large number of genes present in all three. For example, the protein digestion 
and absorption pathway and ECM receptor interaction pathway contain genes that overlap 
with those in the focal adhesion pathway but the former did not contain FLNC. In addition, 
ECM organization involves proteolysis which links this pathway to the protein digestion and 
absorption pathway. Similarly, the ECM receptor interaction pathway is also related to the 
focal adhesion pathway, as focal adhesions form a connection between the actin cytoskeleton 
of the cell and the extracellular matrix [14]. Given that the protein digestion and absorption 
pathways are not cardiac specific and the ECM receptor interaction pathway did not directly 
involve FLNC, these two pathways were not investigated further.
The IPA software package was used to confirm the KEGG pathway analysis performed by 
WebGestalt and identified the integrin linked kinase (ILK) canonical pathway and the 
hepatic fibrosis canonical pathway as most statistically significant. The ILK signalling 
pathway is involved in the regulation of cell adhesion, migration, differentiation and 
apoptotic cell death [15] and substantially overlaps with the KEGG focal adhesion pathway. 
In particular, the ILK pathway contains both FLNC and six other genes which are also 
present in the KEGG focal adhesion pathway: PARVB, ITGB8, JUN, MAPK10, MYL7 and 
VCL. The dysregulated hepatic fibrosis canonical pathway suggests involvement of genes 
that are likely to be commonly involved in the induction of fibrosis in both cardiac and liver 
tissue. The hepatic fibrosis pathway, however, did not relate to GO terms identified by 
WebGestalt and g:GOSt and, therefore, was not further investigated.
Analysis of the dysregulated genes in the focal adhesion pathway showed a possible link to 
the regulation of the actin cytoskeleton. Focal adhesions form between the actin cytoskeleton 
and extracellular matrix and have the ability to act as signalling transduction platforms [16]. 
Actin filaments are connected to transmembrane receptors of the integrin family via 
junctional plaque proteins. In addition, there are a number of proteins present in the focal 
adhesion pathway, for example paxillin, filamin and vinculin, which interact with the tails of 
the integrin subunits either directly or indirectly. These interactions have both a structural 
component, linking them to the actin cytoskeleton, and a role in signal transduction [17].
Comparison of the ILK pathway to the focal adhesion pathway reveals important similarities 
including the presence of FLNC. ILK has been located in focal adhesions and fibrillar 
adhesions [18] and is known to interact with multiple focal adhesion proteins, including 
PINCH, alpha-parvin and paxillin [18]. Additionally the proteins in the ILK pathway are 
involved in cell adhesion, cytoskeleton organization and actin reorganization similarly to 
those in the focal adhesion pathway (Appendix Fig. A.2 and Fig. 4).
Previous studies have identified the KEGG focal adhesion and ILK canonical pathways as 
vital for cardiac function [19,20]. It is important to highlight that the dysregulated pathways 
in ACM LV samples, annotated differently in different bioinformatics platforms, all 
converge to highlight dysregulated cell adhesion, involved in actin cytoskeleton and ECM 
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organization, as a mechanism in the pathogenesis of ACM associated with the FLNC 
variants. The mechanism seems to differ from those involved in the pathogenesis of ACM 
caused by mutations in genes coding for desmosome proteins.
The focal adhesion pathway also included GSK3b and CTNNB1 genes, which are members 
of the canonical WNT signalling pathway. However, transcript levels of these two genes 
were unchanged in ACM heart samples associated with FLNC variants as compared to 
controls. This is consistent with previous immunohistochemistry analysis which detected no 
apparent reduction of the immunoreactive signal for GSK3b in LV specimens from the same 
ACM cases [9]. Activation of the ILK/focal adhesion pathways is implicated in activation of 
β-catenin which, in turn, binds to the Wnt1 promoter region to upregulate gene transcription 
leading to positive feedback of the WNT/β-catenin pathway [21]. Transcript levels of the 
canonical WNT pathway target genes were upregulated in the ACM hearts. However, 
whether the upregulation was a consequence of activation of the ILK pathway or 
independent of it, or secondary to advanced heart failure, remains unclear. Overall, the 
finding suggests involvement of multiple pathways, particularly those involved in cell 
adhesion in the pathogenesis of ACM caused by FLNC variants.
It is also worth noting that the Alpha-parvin/ILK/Pinch1 (PARVA/ILK/LIMS1) complex, 
which is involved in linking focal adhesions to the cytoskeleton, has been previously 
associated with dilated cardiomyopathy DCM [22]. Although our dataset shows no 
dysregulation of this complex, we did detect a downregulation of Parvin-beta (PARVB), a 
paralog of PARVA, in cardiac samples with FLNC variants compared to control samples. 
Parvin-beta has been found to localise to focal adhesions as a cytoplasmic adaptor protein 
playing part in the connection of integrin receptors to the cytoplasm [23]. Parvin-beta could, 
therefore, be having a similar effect on focal adhesion formation as alpha-parvin, ultimately 
affecting the structure of the cytoskeleton, and thereby contributing to this unique LV 
ACM/DCM cross-over phenotype.
Interestingly, a recent study reported an association of novel missense variants in ILK with 
arrhythmogenic cardiomyopathy [24]. In that study, Brodelh et al. presented evidence that in 
vitro loss of focal adhesion location in mutant cells may be due to disruption of the ILK-
PINCH complex. These findings are in line with data presented in this study that suggest a 
dysregulation of the ILK pathway in ACM cardiac tissue.
Given the limited quantities of extracted RNA we were able to validate by qPCR changes in 
transcript levels of a small number of selected DEGs in the ILK and cell adhesion pathways 
including actin-associated genes. We also confirmed suppression of FLNC in LV samples 
carrying variants in this gene. This appears to be consistent with recent findings that showed 
reduced immunoreactive signal for filamin C in the same tissue samples [9]. This data 
strengthens earlier observations that ACM caused by FLNC variants is associated with a 
predominant left ventricle disease pattern [8,9].
4.1. Limitations
This study has a number of limitations including the material source being paraffin fixed 
tissue and the low yield of intact RNA in such tissues compared to fresh or frozen cardiac 
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tissues, which hampered extensive confirmation of the RNA-seq and bioinformatics 
findings. The relatively small quantity of extracted RNA limited qPCR confirmation 
experiments to 5 and 4 genes from the focal adhesion and adhesion pathways, respectively. 
In addition, the small amount of cardiac tissue available precluded the validation of the 
results at the protein level by Western blotting analysis. The study was also limited by the 
small number of samples available, in part because of the challenges in collecting human 
heart samples and in part because of genetic heterogeneity of human ACM and uncommon 
nature of the FLNC variants.
Given that the heart samples were patients with expressed phenotypes including heart 
failure, it is difficult to discern the primary changes resulting directly from FLNC variants 
from those secondary to cardiac dysfunction, heart failure, and other cardiac pathologies.
5. Conclusion
This is the first study that reports on transcriptomic profiles of cardiac tissue samples from 
patients with ACM associated with FLNC variants. The findings were notable for 
dysregulated ILK and the focal adhesion pathways, potentially affecting the actin 
cytoskeleton organization and leading to impaired function and dysregulated related 
signalling pathways. The findings implicate disruption to these pathways as putative disease 
mechanisms in ACM caused by the FLNC variants. Our data suggests the presence of 
different pathogenic mechanisms between ARVC caused by mutant desmosome proteins, 
which involves the canonical WNT signalling pathway, and ACM caused by FLNC variants, 
which may involve disruption of cell adhesion pathways. As this is the first study reporting 
on the transcriptomic profile of FLNC-associated ACM, these findings need to be confirmed 
by future studies which will focus on the interactions between mutant filamin C and specific 
components of the identified pathways.
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Dysregulated gene expression in ACM cardiac tissue samples carrying FLNC variants. A). 
Volcano plots showing differentially expressed genes (q < 0.05) in ACM samples compared 
to controls. Z score plots showing transcriptional regulators targeting B). upregulated or C). 
downregulated genes. D). Gene set enrichment analysis plot of differentially expressed 
genes showing enrichment of genes involved in cell adhesion. E). Heatmap of dysregulated 
genes in the cell adhesion pathway.
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Map displaying the most enriched GO terms for the FLNC variant carriers vs control group 
using WebGestalt [25]. The enriched GO terms are shown in the context of the ontology 
tree; the stronger the red colour in the GO term boxes, the more significant the enrichment 
is. The GO terms in the white boxes are not significantly enriched but are included in order 
to provide information about the parentage of the enriched terms. gNum, Number of genes 
in the gene set also in the category. (For interpretation of the references to colour in this 
figure legend, the reader is referred to the web version of this article.)
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Biological pathways disrupted in ACM cardiac tissue samples carrying FLNC variants 
identified by IPA analysis. A). Histogram of dysregulated canonical pathways. B). Heatmap 
of DEGs in the ILK pathway. C). Circos plot showing differentially expressed genes in the 
ILK signalling and inflammation pathways.
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The ILK Signalling pathway generated using IPA. The genes with an outer pink border are 
present in this dataset. Those coloured in green are downregulated in the FLNC cardiac 
specimens and those that are coloured in red/pink are upregulated compared to the control 
group.
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